REAGENT RED BLOOD CELLS IH-CELL A1 & B
Report
- Report Number
- 9610824-2018-00087
- Event Type
- Malfunction
- Date Received
- December 10, 2018
- Date of Event
- November 11, 2018
- Report Date
- October 29, 2020
- Manufacturer
- BIO-RAD MEDICAL DIAGNOSTICS GMBH
- Product Code
- QHT
- UDI-DI
- 07611969952243
- PMA / PMN Number
- 125208
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- RI, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THIS IS OUR FINAL REPORT ON THIS EVENT.
THE CUSTOMER REPORTED FALSE NEGATIVE REACTIONS OF SPECIMENS WITH IH-CELL A1&B WHEN TESTED ON IH-1000. THE CUSTOMER STATED THAT THE REACTIONS OF BLOOD GROUP A SAMPLES YIELDED AN UNEXPECTED NEGATIVE REACTION WITH IH-CELL B. HE STATED THAT THE REVERSE TYPE DID NOT MATCH THE FORWARD TYPING. DUE TO THE DISCREPANCY BETWEEN FORWARD AND REVERSE TYPING THE IH-1000 STATED, "ABO NOT INTERPRETABLE" AND NO INCORRECT RESULTS WERE RELEASED. WHEN THE CUSTOMER REPEATED THE REVERSE TYPING IN THE TUBE (USING LISS) IT YIELDED STRONG POSITIVE REACTIONS. SAMPLES WERE SENT TO A REFERENCE LAB AND WERE THERE TYPED CORRECTLY, ALSO IN THE TUBE TEST, WITH NO ENHANCEMENT USED. THE CUSTOMER DID NEITHER RETURN THE SUPPOSEDLY DEFECTIVE PRODUCT FOR INVESTIGATIONAL TESTING NOR THE AFFECTED PATIENT DONOR SAMPLES THAT HAD SHOWED A FALSE NEGATIVE REACTION. THEREFORE OUR CONTROL LABORATORY PERFORMED A TITRATION OF THE IH-CELL B OF THE DEFECTIVE LOT 8839011 WITH A KNOWN GROUP A DONOR SAMPLE. THIS TITRATION WAS CARRIED OUT ON THE IH-CARD NEUTRAL AND IN COMPARISON TO TWO DIFFERENT LOTS OF IH-CELL B (LOT 8835011 AND LOT 8843011). THE SERIAL DILUTION WAS PERFORMED FROM 0 TO 32. EACH OF THE THREE LOTS OF IH-CELL B REACTED WITH THE SERA OF THE KNOWN GROUP A SAMPLE TO THE SAME DILUTION FACTOR (1:16). THERE WAS NO REDUCTION IN THE REACTIVITY WITH A ANTIBODIES FROM IH-CELL B LOT 8839011. OUR QUALITY CONTROL LABORATORY ALSO REVIEWED TESTINGS IN WHICH THE SUPPOSEDLY DEFECTIVE PRODUCT WAS USED. NO ABNORMALITIES COULD BE OBSERVED. A REVIEW OF THE BATCH RECORD DOCUMENTATION SHOWED NO IRREGULARITIES WHICH MIGHT HAVE NEGATIVELY AFFECTED THE QUALITY OF THE ALLEGEDLY DEFECTIVE LOT. THE DONOR SAMPLES WHICH GAVE NEGATIVE RESULTS MAY HAVE WEAK ISOAGGLUTININS. THE TUBE METHOD CAN GIVE STRONGER REACTIONS THAN GEL FILTRATION FOR REVERSE GROUPING. TESTING BY OUR CONTROL LABORATORY CONFIRMED THAT THE ALLEGEDLY DEFECTIVE LOT OF IH-CELL A1&B FUNCTIONS CORRECTLY. A REVIEW OF THE BATCH RECORD DOCUMENTATION SHOWED NO IRREGULARITIES WHICH MIGHT HAVE HAD NEGATIVE INFLUENCES ON THE QUALITY OF THE ALLEGEDLY DEFECTIVE LOT.
THIS IS OUR INITIAL REPORT ON THIS INCIDENT.
THE CUSTOMER REPORTED FALSE NEGATIVE REACTIONS OF SPECIMENS WITH IH-CELL A1&B ON IH-1000. THE CUSTOMER STATED THAT THE REACTIONS OF BLOOD GROUP A SAMPLES WERE FALSE NEGATIVE WITH IH-CELL B. HE ALSO STATED THAT THE REVERSE TYPE DID NOT MATCH THE FRONT TYPE. DUE TO THE DISCREPANCY BETWEEN FORWARD AND REVERSE TYPING THE IH-1000 STATED "ABO NOT INTERPRETABLE" AND NO INCORRECT RESULTS WERE RELEASED. THE CUSTOMER DID NOT RETURN THE SUPPOSEDLY DEFECTIVE PRODUCT FOR "INVESTIGATINAL" TESTING BUT SAID TO RETURN THE SAMPLES THAT HAD CAUSED FALSE NEGATIVE TEST RESULTS. OUR QUALITY CONTROL LABORATORY IS STILL WAITING FOR THESE DONOR SAMPLES. A REVIEW OF THE BATCH RECORD DOCUMENTATION SHOWED NO IRREGULARITIES WHICH MIGHT HAVE NEGATIVELY AFFECTED THE QUALITY OF THE ALLEGEDLY DEFECTIVE LOT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 987346 | REAGENT RED BLOOD CELLS IH-CELL A1 & B | IH-CELL A1 & B; 2X10 ML | QHT | BIO-RAD MEDICAL DIAGNOSTICS GMBH | 8839011 | 07611969952243 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | IH-1000, # (B)(6) | IH-1000, # (B)(6) |